- JP-listed companies
- TAKARA BIO INC.
- Cash flow
TAKARA BIO INC.JP:4974
Market cap
¥94.8B
P/E ratio
-10.5x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 1,347 | 1,687 | 1,722 | 2,568 | 2,691 | 2,921 | 3,220 | 3,554 | 4,050 | 4,279 | 3,611 |
| Cash from operations | 3,558 | 3,021 | 3,584 | 3,935 | 5,783 | 6,339 | 13,943 | 6,985 | 36,897 | 1,711 | 5,844 |
| Capital expenditures | -4,587 | -2,263 | -1,443 | -1,499 | -5,977 | -3,983 | -8,687 | -12,403 | -5,747 | -12,778 | -9,871 |
| Cash from investing | -3,168 | -4,177 | 13,493 | -14,755 | -5,576 | -212 | -3,778 | -7,071 | -6,693 | -13,043 | -10,912 |
| Payments for dividends | -143 | -180 | -216 | -480 | -541 | -841 | -962 | -1,923 | -3,968 | -5,052 | -2,048 |
| Repayments of term debt | -47 | -47 | -47 | -130 | - | - | - | - | - | - | - |
| Cash from financing | -231 | -221 | -280 | -1,205 | -541 | -946 | -1,103 | -2,070 | -4,119 | -5,233 | -2,256 |